Cervical cancer and fertility: hope and choice in distress
Cervical cancer, a malignant tumour common in the female reproductive system, has had a significant impact on the physical and mental health of patients. For women who have not yet given birth or who still have the will to give birth, the question of whether cervical cancer is still gestation is of the greatest concern and concern to them.
The impact of cervical cancer on the reproductive function depends mainly on the stagening of the cancer, the way it is treated and the individual situation of the patient. In the early stages of cervical cancer, i.e. the tumor is confined to the cervix, where there has not yet been a significant in vitro immersion and transfer, if the patient has a strong reproductive need, the doctor, after an overall assessment of the condition, will consider the use of surgical treatment to preserve the function of reproduction. This procedure, which is usually a widespread cervical hysterectomy and pelvic lymphoma hysterectomy, preserves the uterus and preserves the possibility of procreation for the patient, as opposed to traditional hysterectomy. However, this procedure does not apply to all early cervical cancer patients and requires strict compliance with a range of conditions, such as smaller tumour diameters, lymphocytal hysteresis immersion, etc., and close post-operative follow-up to monitor tumour relapses, as surgery that retains reproductive function may increase the risk of local recurrence.
The process of pregnancy preparation is also fraught with challenges for patients who have undergone reproductive maintenance. Since the operation may have some impact on the structure and functioning of the cervix, e.g., leading to incomplete cervical functioning, the probability of miscarriages and premature births during pregnancy increases. As a result, such patients need a comprehensive pre-conception assessment prior to pregnancy, including cervical examination. Cervical hysterectomy may be required before or during pregnancy to strengthen the support of the cervix and to reduce the risk of miscarriage or premature birth if the cervical function is found to be inadequate. During pregnancy, patients also need to be monitored more closely, including regular ultrasound to observe cervical length, cervix contraction and, if necessary, in-patient foetal care.
In the case of persons with cervix cancer in the medium and long term, since the tumour is already beyond the scope of the cervix and can cause uterine, vaginal, ceremonial and even remote transfer, there is usually a need for comprehensive treatments such as uterine hysterectomy, decomposition and chemotherapy, which tend to cause irreversible damage to the reproductive function, with almost no possibility of natural gestation after treatment. However, with the development of medical technology, some young patients who have long-term control of their post-synthetic conditions and have the will to give birth may consider, with the assessment and assistance of specialized reproductive medical centres, the use of assistive reproductive techniques, such as the preservation of embryos and ovary tissues, in order to achieve their reproductive wish at the appropriate time, through legal means, such as surrogacy, which is strictly enforced in the country only within the limits provided for by specific laws.
Cervical cancer does not mean an absolute loss of pregnancy-pregnancy opportunities, but it requires a multidisciplinary team of patients, gynaecologists and specialists in reproductive medicine to work together to develop individualized treatment programmes and fertility programmes based on the specific circumstances of cancer. In this process, patients must be fully aware of the advantages and disadvantages of the various treatment options, actively cooperate with treatment and follow-up, and work to realize their reproductive dream while fighting cancer. However, in any event, the health of life remains the primary consideration, and the possibility of childbearing is carefully explored while safeguarding the quality and duration of life of the patient.
Cervical cancer
